Zapanta VQ, Monzon-Pajarillo AK and Santiago APD for the Philippine Pediatric Society (PPS), Philippine
Society of Newborn Medicine (PSNbM) and the Philippine Academy of Ophthalmology– Retinopathy of
Prematurity Working Group (PAO-ROPWG). Retinopathy of Prematurity Philippine Preventive Care Plan Strategy.
A Consensus Statement of the Philippine Pediatric Society (PPS), Philippine Society of Newborn Medicine
(PSNbM) and the Philippine Academy of Ophthalmology – Retinopathy of Prematurity Working Group (PAO-
ROPWG). Phil J Ophthalmol 2020; 45(2): 58-64.
Zapanta VQ, et al for the PSNbM, PAO-ROPWG (2020). Retinopathy of Prematurity Philippine Preventive Care Plan Strategy. A
Consensus Statement of the Philippine Pediatric Society (PPS), Philippine Society of Newborn Medicine (PSNbM) and the Philippine
Academy of Ophthalmology – Retinopathy of Prematurity Working Group (PAO-ROPWG). Phil J Ophthalmol 2020; 45(2): 58-64.
Pediatric Ophthalmology Concerns
Error of
refraction
*Myopia
Strabismus
*Esotropia
Amblyopia
03
Lens Opacity
04
Laser & Anti
VEGF Sequelae
05
Retinal Surgery
Sequelae
06
02
01
https://www.oscarwylee.com.au/
CONTROL
BIGGER PRETERMS, No ROP
(Underrepresented)
Very small
preterms, no ROP
Preterm w ROP
No treatment
Preterm w ROP
With treatment
● Odds of amblyopia increased with
younger GA
</= 28 wks compared to term
● Placental insufficiency tripled
amblyopia odds
● ROP with treatment: 15x odds
● Bilateral amblyopia highest
for treated ROP
● Anisometropia associated
with extreme prematurity
● Refractive anisometropic
amblyopia more common
● High myopia or high
hyperopia rare
● Myopia highest for treated
ROP
Esotropia associated with:
○ Weeks of prematurity (OR 1.11)
○ Anisometropia (OR 3.09)
○ Hypermetropia (OR 4.17)
Nystagmus associated with:
○ ROP (OR 7.5)
○ Anisometropia (OR 5.2)
○ Myopia (OR 11.1)
Strab: 3 (2.1%)
Nys: 1 (1.5%)
Strab: 9 (6.6%)
Nys: 2 (1.5%)
Strab: 16 (17.4%)
Nys: 4 (4.3%)
Strab: 2 (11.1%)
Nys: 1 (5.6%)
Strab: 13 (27.1%)
Nys: 5 (10.4%)
Strab: 9 (60%)
Nys: 4 (26/7%)
Strab: 3 (2.1%)
Nys: 1 (1.5%)
Strab: 9 (6.6%)
Nys: 2 (1.5%)
Strab: 16 (17.4%)
Nys: 4 (4.3%)
Strab: 2 (11.1%)
Nys: 1 (5.6%)
Strab: 13 (27.1%)
Nys: 5 (10.4%)
Strab: 9 (60%)
Nys: 4 (26/7%)
STRABISMUS
● Esotropia (ET) more frequent than exotropia
● Most strabismus within first 10 years
NYSTAGMUS
● Perinatal adverse events strongest predictor (OR 15.8;
p=0.002)
-42 eyes (25 patients)
-mean logMar 0.83 (20/135) to 0.63 (20/85)
-myopic shift >/= 1D in 21 eyes (62%)
between age 5-8
-Stage 4A dominant eyes showed
improvement by age 5-8
-Stage 4B eyes: no significant BCVA
improvement
After Vitrectomy for Stage 4 ROP
1. Tachibana K, Iwahashi C, Kuniyoshi K, Kusaka S. Long-term visual function and refractive changes after vitrectomy for stage 4
retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2025 Jul;263(7):2041-2048. doi: 10.1007/s00417-025-06801-0. Epub 2025
Mar 22. PMID: 40119916; PMCID: PMC12373698.
https://drswatisinkar.com.au/
● 61 eyes, 42 patients
● retrospective
● 4 years follow up
● Mean decimal BCVA at follow up: 0.23 (20/100)
+- 0.25 (HM to 1.2)
● 23 (54%) BCVA 0.4 (20/50)
● Mean refractive error was −10.1 ± 5.0 D
● 37 eyes (75.5%) having high myopia (>−6.0 D).
Lens-sparing vitrectomy
(+ antiVEGF) for St 4A ROP
1. Iwahashi C, Kurihara T, Kuniyoshi K, Kusaka S. Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A
Retinopathy of Prematurity. Int J Mol Sci. 2023 Jan 26;24(3):2416
https://drswatisinkar.com.au/
Cataracts in ROP
Systemi
c
Metabolic acidosis, sepsis
Post Treatment
03
01
Khokhar S, Surve A, Verma S, Azad S, Chandra P, Dhull C, Vohra R. Cataract in retinopathy of prematurity - A review. Indian J Ophthalmol.
2022 Feb;70(2):369-377
Complicated
cataract
02
Associated with RD/Stage 5
Cryo, Laser, AntiVEGF, Vitrectomy
TVL, Anterior Segment Ischemia, Uveal Effusion
Steroid Induced
After Stage 5 ROP
● Buckle or band effect:
○ Myopia
○ Amblyopia
○ anisometropia
● Look for postop sequelae:
○ corneal changes,
○ glaucoma,
○ cataract,
○ uveitis,
○ retinal tears, redetachment
● Refraction, best correction
● Low vision management
Sen P, Jain S, Bhende P. Stage 5 retinopathy of prematurity: An update. Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):205-
215. doi: 10.4103/tjo.tjo_61_18. PMID: 30637192; PMCID: PMC6302569.
Ophthalmic
Sequelae
Late
childhood,
Early
Adulthood
Myopia
(& other refractive errors)
Strabismus
Ocular hypertension,
glaucoma
Corneal aberrations
Retinal tears and detachments,
ERM, foveal anomalies
01
02
03
04
1. Downes RA, Rachitskaya AV. Ophthalmic sequelae of prematurity in late childhood and adulthood: A review. Clin Exp Ophthalmol. 2024
Apr;52(3):355-364.
Slides Courtesy of the ROPWG
ROP
Life long
ophthalmic
care and
follow-up
CREDITS: This presentation template was
created by Slidesgo, including icons by
Flaticon, infographics & images by Freepik
Thank
you
kidseyes@health-channel.com
Please keep this slide for attribution
https://www.voanews.com/
https://www.voanews.com/

Pediatric Ophthalmology Concerns after ROP

  • 5.
    Zapanta VQ, Monzon-PajarilloAK and Santiago APD for the Philippine Pediatric Society (PPS), Philippine Society of Newborn Medicine (PSNbM) and the Philippine Academy of Ophthalmology– Retinopathy of Prematurity Working Group (PAO-ROPWG). Retinopathy of Prematurity Philippine Preventive Care Plan Strategy. A Consensus Statement of the Philippine Pediatric Society (PPS), Philippine Society of Newborn Medicine (PSNbM) and the Philippine Academy of Ophthalmology – Retinopathy of Prematurity Working Group (PAO- ROPWG). Phil J Ophthalmol 2020; 45(2): 58-64.
  • 6.
    Zapanta VQ, etal for the PSNbM, PAO-ROPWG (2020). Retinopathy of Prematurity Philippine Preventive Care Plan Strategy. A Consensus Statement of the Philippine Pediatric Society (PPS), Philippine Society of Newborn Medicine (PSNbM) and the Philippine Academy of Ophthalmology – Retinopathy of Prematurity Working Group (PAO-ROPWG). Phil J Ophthalmol 2020; 45(2): 58-64.
  • 7.
    Pediatric Ophthalmology Concerns Errorof refraction *Myopia Strabismus *Esotropia Amblyopia 03 Lens Opacity 04 Laser & Anti VEGF Sequelae 05 Retinal Surgery Sequelae 06 02 01 https://www.oscarwylee.com.au/
  • 13.
    CONTROL BIGGER PRETERMS, NoROP (Underrepresented) Very small preterms, no ROP Preterm w ROP No treatment Preterm w ROP With treatment
  • 17.
    ● Odds ofamblyopia increased with younger GA </= 28 wks compared to term ● Placental insufficiency tripled amblyopia odds ● ROP with treatment: 15x odds
  • 18.
    ● Bilateral amblyopiahighest for treated ROP ● Anisometropia associated with extreme prematurity ● Refractive anisometropic amblyopia more common ● High myopia or high hyperopia rare ● Myopia highest for treated ROP
  • 20.
    Esotropia associated with: ○Weeks of prematurity (OR 1.11) ○ Anisometropia (OR 3.09) ○ Hypermetropia (OR 4.17)
  • 23.
    Nystagmus associated with: ○ROP (OR 7.5) ○ Anisometropia (OR 5.2) ○ Myopia (OR 11.1)
  • 27.
    Strab: 3 (2.1%) Nys:1 (1.5%) Strab: 9 (6.6%) Nys: 2 (1.5%) Strab: 16 (17.4%) Nys: 4 (4.3%) Strab: 2 (11.1%) Nys: 1 (5.6%) Strab: 13 (27.1%) Nys: 5 (10.4%) Strab: 9 (60%) Nys: 4 (26/7%)
  • 28.
    Strab: 3 (2.1%) Nys:1 (1.5%) Strab: 9 (6.6%) Nys: 2 (1.5%) Strab: 16 (17.4%) Nys: 4 (4.3%) Strab: 2 (11.1%) Nys: 1 (5.6%) Strab: 13 (27.1%) Nys: 5 (10.4%) Strab: 9 (60%) Nys: 4 (26/7%) STRABISMUS ● Esotropia (ET) more frequent than exotropia ● Most strabismus within first 10 years NYSTAGMUS ● Perinatal adverse events strongest predictor (OR 15.8; p=0.002)
  • 38.
    -42 eyes (25patients) -mean logMar 0.83 (20/135) to 0.63 (20/85) -myopic shift >/= 1D in 21 eyes (62%) between age 5-8 -Stage 4A dominant eyes showed improvement by age 5-8 -Stage 4B eyes: no significant BCVA improvement After Vitrectomy for Stage 4 ROP 1. Tachibana K, Iwahashi C, Kuniyoshi K, Kusaka S. Long-term visual function and refractive changes after vitrectomy for stage 4 retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2025 Jul;263(7):2041-2048. doi: 10.1007/s00417-025-06801-0. Epub 2025 Mar 22. PMID: 40119916; PMCID: PMC12373698. https://drswatisinkar.com.au/
  • 39.
    ● 61 eyes,42 patients ● retrospective ● 4 years follow up ● Mean decimal BCVA at follow up: 0.23 (20/100) +- 0.25 (HM to 1.2) ● 23 (54%) BCVA 0.4 (20/50) ● Mean refractive error was −10.1 ± 5.0 D ● 37 eyes (75.5%) having high myopia (>−6.0 D). Lens-sparing vitrectomy (+ antiVEGF) for St 4A ROP 1. Iwahashi C, Kurihara T, Kuniyoshi K, Kusaka S. Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity. Int J Mol Sci. 2023 Jan 26;24(3):2416 https://drswatisinkar.com.au/
  • 40.
    Cataracts in ROP Systemi c Metabolicacidosis, sepsis Post Treatment 03 01 Khokhar S, Surve A, Verma S, Azad S, Chandra P, Dhull C, Vohra R. Cataract in retinopathy of prematurity - A review. Indian J Ophthalmol. 2022 Feb;70(2):369-377 Complicated cataract 02 Associated with RD/Stage 5 Cryo, Laser, AntiVEGF, Vitrectomy TVL, Anterior Segment Ischemia, Uveal Effusion Steroid Induced
  • 41.
    After Stage 5ROP ● Buckle or band effect: ○ Myopia ○ Amblyopia ○ anisometropia ● Look for postop sequelae: ○ corneal changes, ○ glaucoma, ○ cataract, ○ uveitis, ○ retinal tears, redetachment ● Refraction, best correction ● Low vision management Sen P, Jain S, Bhende P. Stage 5 retinopathy of prematurity: An update. Taiwan J Ophthalmol. 2018 Oct-Dec;8(4):205- 215. doi: 10.4103/tjo.tjo_61_18. PMID: 30637192; PMCID: PMC6302569.
  • 42.
    Ophthalmic Sequelae Late childhood, Early Adulthood Myopia (& other refractiveerrors) Strabismus Ocular hypertension, glaucoma Corneal aberrations Retinal tears and detachments, ERM, foveal anomalies 01 02 03 04 1. Downes RA, Rachitskaya AV. Ophthalmic sequelae of prematurity in late childhood and adulthood: A review. Clin Exp Ophthalmol. 2024 Apr;52(3):355-364.
  • 43.
    Slides Courtesy ofthe ROPWG ROP Life long ophthalmic care and follow-up
  • 44.
    CREDITS: This presentationtemplate was created by Slidesgo, including icons by Flaticon, infographics & images by Freepik Thank you kidseyes@health-channel.com Please keep this slide for attribution https://www.voanews.com/ https://www.voanews.com/

Editor's Notes

  • #1 Good afternoon everyone. Thank you for the opportunity to talk to you about pediatric ophthalmology concerns after a Retinopathy of Prematurity or ROP diagnosis
  • #2 The only disclosure I have is that AI was used to beautify most slides in this deck
  • #3 This is the outline of my report today
  • #4 The learner is expected to achieve the following outcomes at the end of this session
  • #5 The ROP Preventive care plan strategy is published in the PJO, as well as the VRSP
  • #6 Key recommendations for screening include screening babies born less than or equal 32 wks, or with a birth weight less than or equal to 1500g, or preterms less than 36 weeks with STOP… sepsis, transfusion, oxygen use, and prematurity course that is less than comforting
  • #7 The gist of this lecture are the following pedia ophtha concerns: EOR< Strabismus, amblyopia, Laser and anti VEGF sequelae, retinal surrey sequalae, and lean opacity that can be a sequelae of both the disease or treatment
  • #8 ohannes Gutenberrg University, in recent years have conducted the Gutenberg Prematurity Eye Study, and more recently the Gutenberg Prematurity Study Young.
  • #9 In both studies they evaluated visual acuity, refraction, presence of amblyopia, lens opacification, strabismus, nystagmus, and their vision related quality of life
  • #10 The Gutenberg Prematurity study young is an ongoing retrospective cohort, where 1898 eyes are included. Children born preterm between 2003 to 2018, were evaluated at age 4-17
  • #11 This was their randomization protocol
  • #12 They have 6 categories Term, 3 groups of Preterms without ROP 33-36 wks, Preterm 29-32 wks, and less than 28 wks 2 groups of preterms with ROP: treated and non treated
  • #14 The ophthalmologic exam done were as follows
  • #15 Key findings of this study, preterms have a poorer distance vision, are more myopic, and larger lens opacification
  • #16 Preterm treated ROP showed 57% incidence
  • #17 Odds of amblyopia increased with younger GA </= 28 wks compared to term Placental insufficiency tripled amblyopia odds ROP with treatment: 15x odds
  • #18 Bilateral amblyopia highest for treated ROP Anisometropia associated with extreme prematurity Refractive anisometropic amblyopia more common High myopia or high hyperopia rare Myopia highest for treated ROP
  • #19 For strabismus, notice that groups 4, 5, 6… small preterms, and thos e with ROP showed a higher incidence. Highest for preterms treated ROP
  • #20 Esotropia associated with: Weeks of prematurity (OR 1.11) Anisometropia (OR 3.09) Hypermetropia (OR 4.17)
  • #21 Top left shows graphical the strabismus in patients with treated ROP Top right showed the type of strabismus, with esotropia more common Bottom left or C, shows strabismus as it relates to ROP stage, most common in St 3 Bottom right shows visual acuity in log mar (0 is 20/20), vision being weakest for treated ROP
  • #22 Nystagmus is also most common in the treated ROP group
  • #23 Nystagmus associated with: ROP (Odds Ratio 7.5) Anisometropia (OR 5.2) Myopia (OR 11.1)
  • #24 You see this again in this logmar representation… Treated ROP eyes, for stage 3-5 showing higher prevalence
  • #25 In the Gutenberg prematurity study, this was very similar to the first prematurity study young, except they studied adults age 18-52… Their studies stress the important of lifelong monitoring of preterm babies
  • #26 The same grouping 1 is control 3 grps of preterms without ROp And 2 grps with ROP, one treated and one non treated
  • #27 This were the prevalence of strabismus and nystagmus, more prominent in the group with ROP, esp in the group that was treated
  • #28 Esotropia (ET) was more frequent than exotropia Most strabismus occur within first 10 years Perinatal adverse events strongest predictor (OR 15.8; p=0.002) of nystagmus with odds ration of 16
  • #29 Multivariate regression analysis showed an OR of close to 1 for low GA; and varying refractions, with OR of 3-10 for the different refractive errors. Note that there is myopia that correlated with strabismus
  • #30 In general, ROP w treatment had poorest visual outcome and socioemotional QoL AMlbyopia more frequent in preterms Distance vision correlated with gestational age, birth weight, ROP treatment, ROP, and perinatal adverse events VR QOL lower in preterms
  • #31 The gutenberg studies have also been reporting about the cornea, biometry, fovea, optic nerve of these preterms who are now all grown.
  • #32 These are the papers of the Gutenberg studies I used for this report
  • #33 Let us now compare use of anti VEGF vs laser
  • #34 Many studies support that antiVEGF has a lower risk of myopia and better refractive outcomes
  • #35 But there are studies that report no difference between the 2
  • #36 Further, there s a study that showed treated and non treated eyes did not show any difference in outcomes
  • #37 There are the references for Antivegf vs laser portion
  • #38 What happens after stage 4 ROP… myopic shift of more than 1D is documented in 60% Continued improvement in vision over time observed for stage 4A but not for stage 4B
  • #39 BcVA is about 20/100; with a mean refractive error of -10D. More than 75% have high myopia
  • #40 Cataracts in ROP can be from systemic associations, such as metabolic acidosis and sepsis; complicated cataracts from RD or Stage 5 ROP, and post treatment
  • #41 After stage 5 ROP, the band can cause myopia, amblyopia, anisometropia As PO, we also look for other problems so that they can be addressed or referred as necessary Refraction need to be performed And Low vision referral is often required
  • #42 Ophthalmic sequelae is outline in this slide.. And can come or be recognized years later.
  • #43 If This lecture can achieve one thing, it should be the realization that a diagnosis of ROP, regardless of wether the patient is treated or note, requires a lifelong ophthalmic care and follow-up
  • #44 Thank you everyone.